雷公藤红素抗肿瘤作用及机制研究进展

doi:10.19586/j.2095-2341.2022.0167

生物技术进展 ›› 2023, Vol. 13 ›› Issue (1): 77-82.DOI: 10.19586/j.2095-2341.2022.0167

雷公藤红素抗肿瘤作用及机制研究进展

董立强(), 王斌, 苏适, 刘东琦

绥化学院，黑龙江绥化 152061

收稿日期:2022-10-11 接受日期:2022-11-01 出版日期:2023-01-25 发布日期:2023-02-07
作者简介:董立强 E-mail: dlq1930@126.com
基金资助:
绥化学院科学技术研究项目(K201701003);黑龙江省大学生创新创业项目(202010236028);绥化学院药食同源特色产品开发与应用创新团队项目(SIT05005)

Progress on Celastrol in Anti-tumor Effects and Mechanism

Liqiang DONG(), Bin WANG, Shi SU, Dongqi LIU

Suihua University，Heilongjiang Suihua 152061，China

Received:2022-10-11 Accepted:2022-11-01 Online:2023-01-25 Published:2023-02-07

摘要/Abstract

摘要：

雷公藤红素是我国传统中药雷公藤中的天然活性成分，具有抗类风湿、抗炎、抗肿瘤等多种生物学活性。近年来，雷公藤红素由于低毒、多靶点、广谱性等优势，在抗肿瘤治疗中备受关注。雷公藤红素可以通过调控PI3K/AKT、NF-κB、MAPK和STAT3等多种信号通路抑制肿瘤增殖、侵袭和转移，诱导肿瘤细胞凋亡。综述了雷公藤红素的抗肿瘤作用及机制，以期促进雷公藤红素的深入研究与应用。

关键词: 雷公藤红素, 细胞凋亡, 信号通路, 抗肿瘤

Abstract:

Celastrol is one of the natural active ingredient in traditional Chinese medicine Tripterygium wilfordii， which has many biological activities such as anti-rheumatoid， anti-inflammatory， anti-tumor and so on. In recent years， celastrol has attracted much attention in anti-tumor therapy due to its advantages of low toxicity， multiple targets and broad spectrum. Celastrol can inhibit tumor proliferation， invasion and metastasis， and induce tumor cell apoptosis via regulating various signaling pathways such as PI3K/AKT， NF-κB， MAPK and STAT3 pathway. This paper summarized the anti-tumor effects and mechanism of celastrol， in order to provide reference for the future research.

Key words: celastrol, apoptosis, signaling pathway, anti-tumor

中图分类号:

R284.1

董立强, 王斌, 苏适, 刘东琦. 雷公藤红素抗肿瘤作用及机制研究进展[J]. 生物技术进展, 2023, 13(1): 77-82.

Liqiang DONG, Bin WANG, Shi SU, Dongqi LIU. Progress on Celastrol in Anti-tumor Effects and Mechanism[J]. Current Biotechnology, 2023, 13(1): 77-82.

参考文献 58

1	LU Y, LIU Y, ZHOU J W, et al.. Biosynthesis, total synthesis, structural modifications, bioactiity, and mechanism of action of the quinone-methide triterpenoid celastrol[J]. Med. Res. Rev., 2021, 41(2): 1022-1060.
2	QIU N S, LIU Y, LIU Q, et al.. Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy[J/OL]. Biomaterials, 2021, 269: 120604[2020-12-17]. .
3	CARUSO F, SINGH M, BELLI S, et al.. Interrelated mechanism by which the methide quinone celastrol, obtained from the roots of Tripterygium wilfordii, inhibits main protease 3CL of COVID-19 and acts as superoxide radical scavenger[J/OL]. Int. J. Mol. Sci., 2020, 21(23): 9266[2020-10-04]. .
4	WANG Y Q, LI C L, GU J Y, et al.. Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling[J]. J. Cell Mol. Med., 2020, 24(1): 941-953.
5	SHI J F, LI J X, XU Z Y, et al.. Celastrol: a review of useful strategies overcoming its limitation in anticancer application[J/OL]. Front Pharmacol., 2020, 11: 558741[2020-11-18]. .
6	NG S W, CHAN Y, CHELLAPPAN D K, et al.. Molecular modulators of celastrol as the key stones for its diverse pharmacological activities[J]. Biomed. Pharmacother., 2019, 109: 1785-1792.
7	KHAN M G M, WANG Y. Cell cycle-related clinical applications[J]. Methods Mol. Biol., 2022, 2579: 35-46.
8	QIAN J, ZHANG Z, HAN X, et al.. Radiosensitizing effect of celastrol by inhibiting G2/M phase arrest induced by the c-myc gene of human SW1353 chondrosarcoma cells: network and experimental analyses[J/OL]. Biomed. Res. Int., 2022: 1948657[2022-01-31]. .
9	SHA M, YE J, LUAN Z Y, et al.. Celastrol induces cell cycle arrest by MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in gastric cancer[J/OL]. Cancer Cell Int., 2015, 15: 101[2015-10-24]. .
10	FRIEDAN J R, RICHBART S D, MERRITT J C, et al.. Capsaicinoids: multiple effects on angiogenesis, invasion and metastasis in human cancers[J/OL]. Biomed. Pharmacother., 2019, 118: 109317[2019-10-01]. .
11	DU S H, SONG X Y, LI Y, et al.. Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells[J/OL]. Sci. Rep., 2020, 10(1): 11273[2020-07-09]. .
12	KIM Y, KANG H, JANG S W, et al.. Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metallo proteinase-9 expression[J]. Cell Physiol. Biochem., 2011, 28(2): 175-184.
13	HARLOZINSKA A. Progress in molecular mechanisms of tumor metastasis and angiogenesis[J]. Anticancer Res., 2005, 25(5): 3327-3333.
14	YANG F, GUO Z H, SHI L Q, et al.. Antiangiogenic and antitumor therapy for retinoblastoma with hypoxia-inducible factor-1α siRNA and celastrol co-delivery nanomicelles[J]. J. Biomed. Nanotechnol., 2020, 16(10): 1471-1481.
15	GAO Y F, ZHOU S, PANG L Z, et al.. Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer[J]. Free Radic. Res., 2019, 53(3): 324-334.
16	PANG X F, YI Z F, ZHANG J, et al.. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway[J]. Cancer Res., 2010, 70(3): 1951-1959.
17	YU X L, ZHOU X, FU C L, et al.. Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway[J]. Oncol. Rep., 2015, 34(3): 1129-1136.
18	MOU H, ZHENG Y, ZHAO P, et al.. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria-and Fas/FasL-mediated pathways[J]. Toxicol. In. Vitro., 2011, 25(5): 1027-1032.
19	ELLIS H, MA C X. PI3K inhibitors in breast cancer therapy[J/OL]. Curr. Oncol. Rep., 2019, 21(12):110[2019-12-11]. .
20	DUNCAN L, SHAY C, TENG Y. PI3K isoform-selective inhibitors in cancer[J]. Adv. Exp. Med. Biol., 2020, 1255: 165-173.
21	ZHU B Q, WEI Y W. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway[J]. Cancer Med., 2020, 9(2): 783-796.
22	ZHU Y J, LIU X H, ZHAO P Y, et al.. Celastrol suppresses Glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K/Akt/mTOR signaling pathway[J/OL]. Front. Pharmacol., 2020, 11: 25[2020-02-06]. .
23	KANNAIYAN R, MANU K A, CEN L, et al.. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3K/Akt signaling pathways[J]. Apoptosis, 2011, 16(10): 1028-1041.
24	YAO S S, HAN L, TIAN Z B, et al.. Celastrol inhibits growth and metastasis of human gastric cancer cell MKN45 by down-regulating microRNA-21[J]. Phytother. Res., 2019, 33(6): 1706-1716.
25	BUF T, DI X, YILIN Z, et al.. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway[J]. Anti-cancer Drug., 2018, 29(6): 530-538.
26	SHRIVASTAVA S, JEENGAR M K, REDDY V S, et al.. Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways[J]. Exp. Mol. Pathol., 2015, 98(3): 313-327.
27	LEE J H, WON Y S, PARK K H, et al.. Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling[J]. Apoptosis, 2012, 17(12): 1275-1286.
28	LIN Y G, KUNNUMAKKARA A B, NAIR A, et al.. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway[J]. Clin. Cancer Res., 2007, 13(11): 3423-3430.
29	VERBOOM L, HOSTE E, VANN L G. OTULIN in NF-κB signaling, cell death, and disease[J]. Trends. Immunol., 2021, 42(7): 590-603.
30	YANG F, LIU H, YU Y, et al.. TRIM9 overexpression promotes uterine leiomyoma cell prolif eration and inhibits cell apoptosis via NF-κB signaling pathway[J/OL]. Life Sci., 2020, 257:118101[2020-07-15]. .
31	RASMI R R, SAKTHIVEL K M, GURUVAYOORAPPAN C. NF-κB inhibitors in treatment and prevention of lung cancer[J/OL]. Biomed. Pharmacother., 2020, 130: 110569[2022-10-01]. .
32	TOZAMA K, SAGAWA M, KIZAKI M. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway[J]. Int. J. Oncol., 2011, 39(5): 1117-1122.
33	YAN F, WU Z, LI Z, et al.. Celastrol inhibits migration and invasion of triple-negative breast cancer cells by suppressing interleukin-6 via downregulating nuclear factor-κB (NF-κB)[J/OL]. Med. Sci. Monit., 2020, 26: e922814[2020-09-13]. .
34	WANG Z, ZHAI Z, DU X. Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells[J]. Exp. Ther. Med., 2017, 14(1): 819-824.
35	ChIANG K C, TUSI K H, CHUNG L C, et al.. Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cells[J/OL]. PLoS ONE, 2014, 9: e93151[2014-03-24]. .
36	DAI Y, DESANO J, TANG W, et al.. Natural proteasome inhibitor celastrol suppresses andro gen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB[J/OL]. PLoS ONE, 2010, 5: e14153[2014-03-24]. .
37	YUAN J, DONG X, YAP J, et al.. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy[J/OL]. J. Hematol. Oncol., 2020, 13 (1): 113[2020-08-17]. .
38	ZHU H, LIU X W, CAI T Y, et al.. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway[J]. J. Pharmacol. Exp. Ther., 2010, 334(2): 489-499.
39	HSIEH M J, WANG C W, LIN J T, et al.. Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway[J/OL]. Phytomedicine, 2019, 58: 152805[2019-03-01]. .
40	SANTONI M, MICCINI F, CIMADAMORE A, et al.. An update on investigational therapies that target STAT3 for the treatment of cancer[J]. Expert Opin. Investig. Drug. 2021, 30(3): 245-251.
41	LI X, WANG H, DING J, et al.. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells[J]. Eur. J. Pharmacol., 2019, 842: 146-156.
42	YAN Y F, ZHANG H H, LV Q, et al.. Celastrol suppresses the proliferation of lung adenocarci noma cells by regulating microRNA-24 and microRNA-181b[J]. Oncol. Lett., 2018, 15(2): 2515-2521.
43	RAJENDRAN P, LI F, SHANMUGAM M K, et al.. Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo[J]. Cancer Prev. Res (Phila)., 2012, 5(4): 631-643.
44	SHIN S A, MOON S Y, PARK D, et al.. Apoptotic cell clearance in the tumor microenvironment: a potential cancer therapeutic target[J]. Arch. Pharm. Res., 2019, 42(8): 658-671.
45	ABRAHA A M, KETEMA E B. Apoptotic pathways as a therapeutic target for colorectal cancer treatment[J]. World J. Gastrointest. Oncol., 2016, 8(8): 583-591.
46	BURKE P J. Mitochondria, bioenergetics and apoptosis in cancer[J]. Trends. Cancer, 2017, 3(12): 857-870.
47	CHEN M, YANG J, LI L, et al.. Metabolomics reveals that cysteine metabolism plays a role in celastrol-induced mitochondrial apoptosis in HL-60 and NB-4 cells[J/OL]. Sci .Rep., 2020, 10(1): 471[2020-01-12]. .
48	LIU X, GAO R W, LI M, et al.. The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in celastrol against angiotensin Ⅱ‍-mediated HepG2 cell proliferation[J]. Apoptosis, 2016, 21(11): 1315-1326.
49	DENG H, ZHOU Z, YANG W, et al.. Endoplasmic reticulum targeting to amplify immuno genic cell death for cancer immunotherapy[J]. Nano. Lett., 2020, 20(3): 1928-1933.
50	CHEN Y, OU Y, TAO Y, et al.. Effect and mechanisms of celastrol on the apoptosis of HOS osteosarcoma cells[J]. Oncol. Rep., 2018, 40(4): 2260-2268.
51	REN B, LIU H, GAU H, et al.. Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR[J]. Oncotarget, 2017, 8(54): 93039-93050.
52	FENG L, ZHANG D, FAN C, et al.. ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network[J/OL]. Cell Death Dis., 2013, 4(7): e715[2013-07-11]. .
53	SHARMA S, CARMONA A, SKOWRONEK A, et al.. Apoptotic signalling targets the post-endocytic sorting machinery of the death receptor Fas/CD95[J/OL]. Nat. Commun., 2019, 10(1): 3105[2019-07-15]. .
54	MAEDA K, NAKAYAMA J, TAKI S, et al.. TAK1 limits death receptor Fas-induced proin flammatory cell death in macrophages[J]. J. Immunol., 2022, 209(6): 1173-1179.
55	CHA Z, CHENG J, XIANG H, et al.. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway[J]. Cancer Chemother. Pharmacol., 2019, 84(4): 719-728.
56	LIN H F, HSIEH M J, HSI Y T, et al.. Celastrol-induced apoptosis in human nasopharyngeal carcinoma is associated with the activation of the death receptor and the mitochondrial pathway[J]. Oncol. Lett., 2017, 14(2): 1683-1690.
57	SUNG B, PARK B, YADAV V R, et al.. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors[J]. J. Biol. Chem., 2010, 285(32): 11498-11507.
58	RAMAMOORTHY P, DANDAWATE P, JENSEN R A, et al.. Celastrol and triptolide suppress stemness in triple negative breast cancer: notch as a therapeutic target for stem cells[J/OL]. Biomedicines, 2021, 9(5): 482[2021-04-28]. .

编辑推荐 0

Metrics

阅读次数

全文

745

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	745

来源	本网站	其他网站

次数	691	54
比例	93%	7%

摘要

401

最新录用	在线预览	正式出版

0	0	401

	来源	本网站

	次数	401
	比例	100%

[1]	徐奔, 覃锐, 向航, 许京淑, 廖子龙, 向金平. 臭椿酮抑制急性骨髓性白血病细胞恶性生物学行为的研究[J]. 生物技术进展, 2022, 12(5): 769-777.
[2]	赵佩, 邹青, 李泽霖. 黄芪甲甙对急性心肌梗死大鼠心室重构和NOX/ROS/TNF⁃α信号通路的影响[J]. 生物技术进展, 2022, 12(5): 778-785.
[3]	陈小巧, 牧仁, 李玉玲. 脐带间充质干细胞的生物学特性及旁分泌作用的研究进展[J]. 生物技术进展, 2022, 12(4): 559-567.
[4]	陈晓光, 潘晓峰, 王帆, 潘宋斌. 人参皂苷Rg1对阿尔茨海默症大鼠BDNF⁃TrkB信号通路的影响[J]. 生物技术进展, 2022, 12(3): 446-451.
[5]	黄乔木, 何艳. 雷帕霉素对糖尿病肾病大鼠足细胞生物学行为及mTOR信号通路的影响[J]. 生物技术进展, 2022, 12(3): 460-466.
[6]	李坤, 金丽华. 果蝇造血器官淋巴腺的研究进展[J]. 生物技术进展, 2022, 12(2): 222-228.
[7]	李征, 郑亚民, 张小农. 镁离子与肿瘤的相关关系[J]. 生物技术进展, 2022, 12(1): 63-67.
[8]	任真,赵金凤,张瑶,谢益敏,周阳,顾杰,施海峰. 钙离子在镉诱导的肾毒性中的作用机理[J]. 生物技术进展, 2019, 9(5): 476-482.
[9]	张旭娟,赵鹏翔,YAO Mawulikplimi Adzavon,李秦剑,谢飞. EBV与TLRs信号通路相互作用机制研究进展[J]. 生物技术进展, 2019, 9(3): 231-239.
[10]	YAO Mawulikplimi Adzavon,赵鹏翔,张旭娟,王丽敏,马雪梅. 巨噬细胞迁移抑制因子分子机制研究进展[J]. 生物技术进展, 2018, 8(5): 389-396.
[11]	张亚婷,靳小艳,钟国徽,厉建伟,李英贤,马雪梅. BAG-1蛋白及其对神经系统疾病调控研究进展[J]. 生物技术进展, 2018, 8(3): 229-236.
[12]	任思蕊,王冰蕊,郭青,冯甜甜,王鼎,高洁,石莉红. 敲除LSD1基因对人慢性髓系白血病K562细胞周期的影响[J]. 生物技术进展, 2018, 8(3): 269-273.
[13]	熊咏民,杨晓莉,张荣强,李宝荣,陈静宏,代晓霞,陈群,谭武红,张峰. 硒在地方病中的防治作用及其分子机制研究进展[J]. 生物技术进展, 2017, 7(5): 501-505.
[14]	胡尼其古丽·阿巴克,阿依努尔·玉苏普,玛依努尔·达吾提,其曼古丽·吐尔洪,依米提·热合曼. 蜂胶中黄酮类化合物药理作用研究进展[J]. 生物技术进展, 2017, 7(1): 13-19.
[15]	高丽,谌颜,扈廷茂,李光鹏. 肌肉生长抑制素基因在哺乳动物中的最新研究进展[J]. 生物技术进展, 2014, 4(6): 381-388.

雷公藤红素抗肿瘤作用及机制研究进展

Progress on Celastrol in Anti-tumor Effects and Mechanism

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 58

相关文章 15

编辑推荐 0

Metrics

本文评价